{
    "id": "561",
    "title": "Asymptomatic Myeloma Prognosis",
    "desc": "The Asymptomatic Myeloma Prognosis predicts risk of progression of asymptomatic (smoldering) multiple myeloma to active myeloma or amyloidosis.",
    "data": {
        "orgreference": [
            {
                "href": "http://www.ncbi.nlm.nih.gov/pubmed/17582068",
                "text": "Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007 Jun 21;356(25):2582-90. PMID:17582068."
            }
        ],
        "other_refer": [
            {
                "href": "",
                "text": ""
            }
        ],
        "evidence": "<p><strong>High risk</strong></p>\n<ul>\n<li>BM plasmacytosis &ge;10% AND</li>\n<li>Serum monoclonal protein &ge;3 g/dL</li>\n</ul>\n<p><strong>Intermediate risk</strong></p>\n<ul>\n<li>BM plasmacytosis &ge;10% AND</li>\n<li>Serum monoclonal protein &lt;3 g/dL</li>\n</ul>\n<p><strong>Low risk</strong></p>\n<ul>\n<li>BM plasmacytosis &lt;10% AND</li>\n<li>Serum monoclonal protein &ge;3 g/dL</li>\n</ul>",
        "facts": "<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td rowspan=\"2\">&nbsp;</td>\n<td colspan=\"3\">\n<p><strong>Risk of progression</strong></p>\n</td>\n<td rowspan=\"2\">\n<p><strong>Median time to progression</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>At 5 years</strong></p>\n</td>\n<td>\n<p><strong>At 10 years</strong></p>\n</td>\n<td>\n<p><strong>At 15 years</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>High risk</strong></p>\n</td>\n<td>\n<p>69%</p>\n</td>\n<td>\n<p>77%</p>\n</td>\n<td>\n<p>87%</p>\n</td>\n<td>\n<p>27 months (~2 years)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intermediate risk</strong></p>\n</td>\n<td>\n<p>43%</p>\n</td>\n<td>\n<p>64%</p>\n</td>\n<td>\n<p>70%</p>\n</td>\n<td>\n<p>93 months (~8 years)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Low risk</strong></p>\n</td>\n<td>\n<p>15%</p>\n</td>\n<td>\n<p>33%</p>\n</td>\n<td>\n<p>39%</p>\n</td>\n<td>\n<p>228 months (~19 years)</p>\n</td>\n</tr>\n</tbody>\n</table>",
        "estimation": [],
        "primary_complains": [
            "Extremity Pain",
            "Neck Pain",
            "Pain",
            "Weakness"
        ],
        "disease_treated": [
            "Cancer",
            "Hematologic Malignancy",
            "Multiple Myeloma"
        ],
        "logic": "// Asymptomatic Myeloma Prognosis\nvar calc_output = [];\n\nvar bmp; \t\t\t\t// bone marrow plasmacytosis \nvar smp; \t\t\t\t// serum monoclonal protein\nvar risk_group = '';\t// risk group\nvar risk_percent = '';\t// risk in percentage\nvar time = '';\t\t\t// time to progression in years\nvar msg = ''; \t\t\t// message\n\nif (bmp == 0 && smp == 0) {\n\trisk_group = 'High';\n\trisk_percent = '69%'; \n\tmsg = 'Risk of progression at 5 years<br/><br/><strong>77%</strong> at 10 years<br/><strong>87%</strong> at 15 years';\n\ttime = '27';\n}\nif (bmp == 0 && smp == 1) {\n\trisk_group = 'Intermediate';\n\trisk_percent = '43%'; \n\tmsg = 'Risk of progression at 5 years<br/><br/><strong>64%</strong> at 10 years<br/><strong>70%</strong> at 15 years';\n\ttime = '93';\n}\n\nif (bmp == 1 && smp == 0) {\n\trisk_group = 'Low';\n\trisk_percent = '15%';\n\tmsg = 'Risk of progression at 5 years<br/><br/><strong>33%</strong> at 10 years<br/><strong>39%</strong> at 15 years'; \n\ttime = '228';\n}\nif (bmp == 1 && smp == 1) {\n\trisk_group = '';\n\trisk_percent = ''; \n\tmsg = 'Patient does not meet criteria for asymptomatic myeloma (see Pearls/Pitfalls for criteria)';\n\ttime = '';\n}\nif (bmp + smp < 2) {\ncalc_output.push({ // message on app\n    name: 'mini',\n    value: risk_group,\n    value_text: 'risk',\n    message: \"\"\n});\n}\nif (bmp == 1 && smp == 1) {\ncalc_output.push({ // message on app\n    name: 'mini',\n    value: '',\n    value_text: '',\n    message: msg\n});\n}\nif (bmp + smp < 2) {\ncalc_output.push({\n    name: 'risk_group',\n    value: risk_group,\n    value_text: ' risk',\n    message: \"\"\n});\n}\ncalc_output.push({\n    name: 'risk',\n    value: risk_percent,\n    value_text: '',\n    message: msg\n});\nif (bmp + smp < 2) {\ncalc_output.push({\n    name: 'time',\n    value: time,\n    value_text: ' months',\n    message: 'Median time to progression'\n});\n}",
        "inputs": [
            {
                "conditionality": "",
                "default": null,
                "label_en": "Bone marrow plasmacytosis",
                "name": "bmp",
                "optional": false,
                "options": [
                    {
                        "label": "≥10%",
                        "value": 0
                    },
                    {
                        "label": "<10%",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "Average % from bone marrow aspirate and core biopsy",
                "type": "toggle"
            },
            {
                "conditionality": "",
                "default": null,
                "label_en": "Serum monoclonal protein, g/dL",
                "name": "smp",
                "optional": false,
                "options": [
                    {
                        "label": "≥3",
                        "value": 0
                    },
                    {
                        "label": "<3",
                        "value": 1
                    }
                ],
                "show_points": false,
                "tips_en": "On serum protein electrophoresis",
                "type": "toggle"
            }
        ],
        "can_search": [
            "mm",
            "multiple myeloma",
            "myeloma",
            "smoldering myeloma",
            "asymptomatic myeloma",
            "prognosis"
        ],
        "specialty": [
            "Hematology and Oncology"
        ]
    }
}